5 Best Leveraged ETF Areas of Last Week

 | Apr 20, 2020 08:00AM ET

Last week was favorable for Wall Street with the S&P 500, the Dow Jones and the Nasdaq returning about 3%, 2.2% and 6.1%, respectively. Hopes of American businesses reopening, moderation in new virus cases and chances of treatment coming on stream kept markets in the positive territory.

However, if investors can identify the trending investing area amid all this coronavirus chaos, they can easily take a leveraged position on that and book sturdy profits in a short span.

Keeping this in mind, below we highlight a few leveraged ETF areas that were among the toppers last week.

FANG+

The NYSE FANG+ Index includes 10 highly liquid stocks that make up a segment of the technology and consumer discretionary sectors consisting of highly traded growth stocks of technology and tech-enabled companies. These stocks are Facebook (NASDAQ:FB), Apple (NASDAQ:AAPL), Amazon (NASDAQ:AMZN), Netflix (NASDAQ:NFLX), Alphabet (NASDAQ:GOOGL), Alibaba (NYSE:BABA), Baidu (NASDAQ:BIDU), Nvidia, Tesla (NASDAQ:TSLA) and Twitter.

These stocks have been rallying lately as the coronavirus fear has charged up the tech and Internet sector. Global lockdowns have left people binge-watching and benefited media-services provider and production company Netflix. At the same time, widespread work-and-learn-from-home has favored cloud businesses of Microsoft (NASDAQ:MSFT), Amazon, Apple and Alphabet. Also, Amazon and Alibaba gained from online shopping.

As a result, MicroSectors FANG+ Index 3X Inverse Leveraged ETN FNGO (up 22.8%) were the winners last week.

Biotech

Stocks of medical companies that make testing kits and are developing the treatment and vaccine to fight COVID-19 have gained immensely this year. Gilead Sciences (NASDAQ:GILD)’ ABT has launched its third COVID-19 test.

Then there are health-care giants like Johnson & Johnson (NYSE:JNJ) Biotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress ).

Naturally, funds like Direxion Daily S&P Biotech Bull 3x Shares CURE (up 18.8%) had every reason to rally last week.

Semiconductor

Last week was full of good news for the chip space. on better-than-expected first-quarter results. The chip maker’s guidance for the second quarter was also upbeat.

Chinese regulators approved Nvidia’s in December .

If these were not enough, could computing — a hot area in the coronavirus-stricken economy —has been driving demand for chips. Direxion Daily Semiconductor Bull 3x Shares SOXL added 18.8% last week.

Consumer Discretionary

The impending reopening of the U.S. economy as well as the massive Fed and U.S. government stimulus has given the sector a fresh lease of life. Direxion Daily Consumer Discretionary Bull 3X Shares WANT gained 17.3% last week. The underlying index of the fund is heavy on Amazon (23.6%), followed by Home Depot (NYSE:HD) (9.88%), McDonald’s (NYSE:MCD) (6.18%), Nike (NYSE:NKE) (5.24%) and Starbucks (NASDAQ:SBUX) (4.31%).

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Consumer Staples

Though America is planning a reopening, a return to complete normalcy will take time 2 Agricultural ETFs Benefit From the Coronavirus Scare ).

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes